Skip to main content
Finanzoo GmbH Finanzoo GmbH

US Physical Therapy Value Stock - Dividend - Research Selection

Us physical therapy

ISIN: US90337L1089 , WKN: 923954
Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!

How our site works ...

✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month 
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.


Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet

Description of the company

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It provides workforce performance solutions, including onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments for Fortune 500 companies, and other clients comprising insurers and their contractors. As of March 13, 2018, it operated 579 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,

NEWS


Why Concentra’s Quiet Healthcare Business Keeps Winning

2026-10-02
Concentra's Q2 revenue and profit beat estimates, and all eight analysts rate it a Buy, but a leadership transition and a 75% stock rally raise valuation questions.
Yahoo

3 Cash-Producing Stocks with Questionable Fundamentals

2026-09-30
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Yahoo

U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis

2026-09-21
HOUSTON, September 21, 2026--U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that its Board of Directors (the "Board") approved the appointment of Ms. Myra Davis to serve as a member of the Board, effective October 1, 2026.
Yahoo

U.S. Physical Therapy (USPH), What Is Drawing Fresh Attention Now?

2026-09-21
The appointment of Nchacha Etta as Chief Financial Officer has put U.S. Physical Therapy (USPH) back on investor screens, as fresh leadership intersects with renewed debate over the stock’s discounted cash flow valuation. Recent trading has been constructive, with U.S. Physical Therapy showing a 29.87% 90 day share price return and a 5.92% 1 year total shareholder return, even though the 3 year and 5 year total shareholder returns are still in decline. Compare U.S. Physical Therapy’s renewed...
Yahoo

Will a New CFO and Tighter Cash Flow Lens Change U.S. Physical Therapy's (USPH) Narrative

2026-09-21
Earlier this year, U.S. Physical Therapy appointed Nchacha Etta as Chief Financial Officer, marking a change in leadership over the company’s finance function and capital management responsibilities. The move has drawn fresh attention to how effectively the business converts earnings into cash and how its long-term cash flows are being valued. We’ll now examine how the new CFO’s appointment and sharper focus on cash flow quality may influence U.S. Physical Therapy’s investment...
Yahoo

U.S. Physical Therapy (USPH) Stock Could Be 44% Undervalued After CFO Appointment

2026-09-20
U.S. Physical Therapy has delivered mixed results for long term holders, with the share price down 21.3% over 5 years despite a recent uptick. This puts fresh focus on whether the current US$82.47 level lines up with the cash the business can generate. With the stock back in positive territory over the past year and new leadership in the finance seat, the question now is how well those cash flows support today’s valuation. The share price decline of 21.3% over 5 years means anyone looking at...
Yahoo

Transcript: US Physical Therapy Q2 2026 Earnings Conference Call

2026-09-18
On Thursday, US Physical Therapy (NYSE:USPH) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time
Benzinga

US Physical Therapy (USPH) Taps A Global Finance Veteran As CFO

2026-09-14
On August 14, US Physical Therapy (NYSE:USPH) announced that Nchacha Etta will become the company’s Executive Vice President and Chief Financial Officer, effective September 1. The move closes out a search that began after Jason Curtis stepped in as interim CFO on April 24, and it arrives as the outpatient physical therapy operator works through […]
Yahoo

JP Morgan Maintains Overweight on US Physical Therapy, Raises Price Target to $95

2026-09-11
JP Morgan analyst Benjamin Rossi maintains US Physical Therapy (NYSE:USPH) with a Overweight and raises the price target from $90 to $95.
Benzinga

U.S. Physical Therapy Bets on Hospital Alliances to Drive Visits, Reimbursement

2026-08-27
U.S. Physical Therapy (NYSE:USPH) is pursuing growth through clinic openings, acquisitions and a newer hospital-alliance strategy that Chief Executive Officer Chris Reading said could expand patient volumes and improve reimbursement. Speaking at an investor event, Reading said the company operates
Yahoo